Dysphonia
Conditions
Brief summary
The long-term goal is to transform the diagnosis and treatment of dysphonia by elucidating cervical and cranial neuromuscular mechanisms underlying typical and disordered voicing. The overall objective of this application is to propose and evaluate a novel objective spectrotemporal diagnostic tool measuring functional cervical-cranial muscle network activity in typical and disordered speakers.The purpose of this study is to improve our understanding of how the vocal tract and the muscles of the larynx and the head work at baseline and after vocal fatigue.
Detailed description
Three experiments will be conducted over the 2-year award period. Experiment 1 (Aim 1) will utilize a 16-channel EMG array to characterize cervical-cranial muscle activity networks in typical speakers at baseline and after a vocal loading task. Aim 2 will quantify how cervical muscle networks are perturbed in patients with two different types of dysphonia and examine if standard-of-care treatment restores cervical-cranial muscle networks to more typical states. In Experiment 2 (Aim 2), we will measure muscle networks in patients with muscle tension dysphonia before and after a course of voice therapy. Patients with muscle tension dysphonia represent an intact butpotentially maladaptive network. In Experiment 3 (Aim 2), we will measure patients with unilateral vocal fold paralysis, representing a neurologically impaired network, before and after a vocal fold injection medialization procedure.
Interventions
DIAGNOSTIC_TESTsurface electromyogram (sEMG)
A device that measures electrical signals from your skin will be connected to those stickers and will make a graph that is characteristic to your vocal function.
DIAGNOSTIC_TESTflexible laryngoscopy
A device that examines the throat and nasal passages. The flexible laryngoscope or scope consists of an eyepiece and a fiber-optic light enclosed in a thin, flexible tube. The scope looks like a strand of black spaghetti with a tiny light on the end of it. The scope is inserted through the nose, and can be moved around to help the doctor see all areas of the nasal passages and throat.
Sponsors
National Institute on Deafness and Other Communication Disorders (NIDCD)
NYU Langone Health
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to 88 Years
Healthy volunteers
Yes
Inclusion criteria
Experimental Group * Age \>18 years; * Patient cohorts diagnosed with muscle tension dysphonia with a recommended treatment of voice therapy. * Patient cohorts diagnosed with unilateral vocal cord paralysis with a recommended treatment of vocal fold injection medialization. * Willingness to complete all clinical/research assessments * Ability to give informed consent (Control Group) * Age \>18 years; * Absence of any organic vocal lesion as determined on flexible laryngoscopy. * Willingness to complete all clinical/research assessments * Ability to give informed consent
Exclusion criteria
Experimental Group: * Any contraindication for wearing the device, such as a known or reported (at any time including during the study): * allergy; * history of head and neck surgery in the past 3 months; * presence of open wound or/and ulcer in close proximity to sEMG sensors; * 'smart' implant with a microcontroller (such as a pain pump or nerve stimulator); * participation in additional clinical research studies using investigational treatments. Control group: * Any contraindication for wearing the device, such as a known or reported (at any time including during the study) allergy; * Abnormal laryngeal structure and function as determined via laryngeal endoscopic exam; * History of head and neck surgery in the past 3 months; * Presence of open wound or/and ulcer in close proximity to sEMG sensors; * 'Smart' implant with a microcontroller (such as a pain pump or nerve stimulator); * Participation in additional clinical research studies using investigational treatments.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in Pitch and Loudness levels in vocal tasks | Baseline visit, 2 week visit, 2 months visit | Both at baseline and after a vocal loading task, muscle network activity using sEMG will be measured in a variety of vocal tasks outlined above in Table 1 to explore the muscle network across different vocal demands and pitch and loudness levels. The pitch and loudness of each task produced at baseline by each participant will be calculated, and visual feedback will be provided to participants using the Real-Time Pitch module of the Computerized Speech Lab (Pentax, Montvale, NJ) to help them reproduce similar pitch and loudness levels during post-loading recordings. |
| Change in Vocal loading task | Baseline visit, 2 week visit, 2 months visit | After baseline sEMG measurements, vocal fatigue will be induced using a vocal loading task of reading in the presence of 70-dB background noise, as described in Sundarrajan 51 The duration of reading that induces self-perceived vocal fatigue varies among vocally-healthy individuals.52 Therefore, we will use the CR10 Physical Exertion Scale adapted for vocal effort to have participants rate their self-perceived participant reported |
| Change in Phonatory Effort (PPE) | Baseline visit, 2 week visit, 2 months visit | Phonatory Effort (PPE) while reading the first section of The Rainbow Passage at up to four time points during the load task. The vocal loading task will end after participants report an increase of at least 2 points in PPE. |
Countries
United States
Outcome results
None listed